Maral Overseas Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 13, 2025, 8:14 pm

Quick Insight

Maral Overseas Ltd, operating in the textiles-spinning-cotton blended industry, currently trades at a price of 49.2 with a market capitalization of 204 Cr. The company shows a P/E ratio, ROE, and ROCE of 20.2%, 1.89%, and 1% respectively. With a net profit of -24 Cr, Maral Overseas faces challenges in profitability. Promoters hold a significant stake of 74.95%, while FIIs have a minimal presence at 0.07%. The company's high borrowings of 449 Cr against reserves of 67 Cr raise concerns about leverage. With a current ratio of 1.76x, Maral Overseas may face liquidity issues. In conclusion, investors should closely monitor the company's financial performance and debt levels to assess its long-term viability.

Competitors of Maral Overseas Ltd

All Competitor Stocks of Maral Overseas Ltd

Quarterly Result

Last Updated: August 20, 2025, 7:15 am

Below is a detailed analysis of the quarterly data for Maral Overseas Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 226.00 Cr.. The value appears to be declining and may need further review. It has decreased from 275.00 Cr. (Mar 2025) to 226.00 Cr., marking a decrease of 49.00 Cr..
• For Expenses, as of Jun 2025, the value is 224.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 264.00 Cr. (Mar 2025) to 224.00 Cr., marking a decrease of 40.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 8.00 Cr..
• For OPM %, as of Jun 2025, the value is 1.00%. The value appears to be declining and may need further review. It has decreased from 4.00% (Mar 2025) to 1.00%, marking a decrease of 3.00%.
• For Other Income, as of Jun 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2025) to 5.00 Cr., marking a decrease of 2.00 Cr..
• For Interest, as of Jun 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.00 Cr. (Mar 2025) to -13.00 Cr., marking a decrease of 13.00 Cr..
• For Tax %, as of Jun 2025, the value is -1.00%. The value appears to be increasing, which may not be favorable. It has increased from -47.00% (Mar 2025) to -1.00%, marking an increase of 46.00%.
• For Net Profit, as of Jun 2025, the value is -13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.00 Cr. (Mar 2025) to -13.00 Cr., marking a decrease of 13.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -3.03. The value appears to be declining and may need further review. It has decreased from -0.06 (Mar 2025) to -3.03, marking a decrease of 2.97.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 5:57 am

Balance Sheet

Last Updated: June 16, 2025, 11:44 am

Below is a detailed analysis of the balance sheet data for Maral Overseas Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 42.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 42.00 Cr..
• For Reserves, as of Mar 2025, the value is 67.00 Cr.. The value appears to be declining and may need further review. It has decreased from 90.00 Cr. (Mar 2024) to 67.00 Cr., marking a decrease of 23.00 Cr..
• For Borrowings, as of Mar 2025, the value is 449.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 476.00 Cr. (Mar 2024) to 449.00 Cr., marking a decrease of 27.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 174.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 150.00 Cr. (Mar 2024) to 174.00 Cr., marking an increase of 24.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 732.00 Cr.. The value appears to be improving (decreasing). It has decreased from 758.00 Cr. (Mar 2024) to 732.00 Cr., marking a decrease of 26.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 337.00 Cr.. The value appears to be declining and may need further review. It has decreased from 346.00 Cr. (Mar 2024) to 337.00 Cr., marking a decrease of 9.00 Cr..
• For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2024) to 1.00 Cr., marking a decrease of 8.00 Cr..
• For Investments, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 393.00 Cr.. The value appears to be declining and may need further review. It has decreased from 402.00 Cr. (Mar 2024) to 393.00 Cr., marking a decrease of 9.00 Cr..
• For Total Assets, as of Mar 2025, the value is 732.00 Cr.. The value appears to be declining and may need further review. It has decreased from 758.00 Cr. (Mar 2024) to 732.00 Cr., marking a decrease of 26.00 Cr..

However, the Borrowings (449.00 Cr.) are higher than the Reserves (67.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Maral Overseas Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is -2.35. This value is below the healthy minimum of 5. It has increased from -3.84 (Mar 23) to -2.35, marking an increase of 1.49.
• For Diluted EPS (Rs.), as of Mar 24, the value is -2.35. This value is below the healthy minimum of 5. It has increased from -3.84 (Mar 23) to -2.35, marking an increase of 1.49.
• For Cash EPS (Rs.), as of Mar 24, the value is 5.90. This value is within the healthy range. It has increased from 3.38 (Mar 23) to 5.90, marking an increase of 2.52.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 31.69. It has decreased from 33.97 (Mar 23) to 31.69, marking a decrease of 2.28.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 31.69. It has decreased from 33.97 (Mar 23) to 31.69, marking a decrease of 2.28.
• For Dividend / Share (Rs.), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 231.29. It has decreased from 247.15 (Mar 23) to 231.29, marking a decrease of 15.86.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 14.39. This value is within the healthy range. It has increased from 8.36 (Mar 23) to 14.39, marking an increase of 6.03.
• For PBIT / Share (Rs.), as of Mar 24, the value is 6.14. This value is within the healthy range. It has increased from 1.14 (Mar 23) to 6.14, marking an increase of 5.00.
• For PBT / Share (Rs.), as of Mar 24, the value is -2.04. This value is below the healthy minimum of 0. It has increased from -4.42 (Mar 23) to -2.04, marking an increase of 2.38.
• For Net Profit / Share (Rs.), as of Mar 24, the value is -2.35. This value is below the healthy minimum of 2. It has increased from -3.84 (Mar 23) to -2.35, marking an increase of 1.49.
• For PBDIT Margin (%), as of Mar 24, the value is 6.22. This value is below the healthy minimum of 10. It has increased from 3.38 (Mar 23) to 6.22, marking an increase of 2.84.
• For PBIT Margin (%), as of Mar 24, the value is 2.65. This value is below the healthy minimum of 10. It has increased from 0.46 (Mar 23) to 2.65, marking an increase of 2.19.
• For PBT Margin (%), as of Mar 24, the value is -0.88. This value is below the healthy minimum of 10. It has increased from -1.78 (Mar 23) to -0.88, marking an increase of 0.90.
• For Net Profit Margin (%), as of Mar 24, the value is -1.01. This value is below the healthy minimum of 5. It has increased from -1.55 (Mar 23) to -1.01, marking an increase of 0.54.
• For Return on Networth / Equity (%), as of Mar 24, the value is -7.42. This value is below the healthy minimum of 15. It has increased from -11.29 (Mar 23) to -7.42, marking an increase of 3.87.
• For Return on Capital Employeed (%), as of Mar 24, the value is 6.56. This value is below the healthy minimum of 10. It has increased from 1.65 (Mar 23) to 6.56, marking an increase of 4.91.
• For Return On Assets (%), as of Mar 24, the value is -1.28. This value is below the healthy minimum of 5. It has increased from -2.51 (Mar 23) to -1.28, marking an increase of 1.23.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 1.18. This value exceeds the healthy maximum of 1. It has increased from 0.64 (Mar 23) to 1.18, marking an increase of 0.54.
• For Total Debt / Equity (X), as of Mar 24, the value is 3.23. This value exceeds the healthy maximum of 1. It has increased from 2.33 (Mar 23) to 3.23, marking an increase of 0.90.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.38. It has decreased from 1.68 (Mar 23) to 1.38, marking a decrease of 0.30.
• For Current Ratio (X), as of Mar 24, the value is 0.97. This value is below the healthy minimum of 1.5. It has decreased from 1.07 (Mar 23) to 0.97, marking a decrease of 0.10.
• For Quick Ratio (X), as of Mar 24, the value is 0.53. This value is below the healthy minimum of 1. It has decreased from 0.55 (Mar 23) to 0.53, marking a decrease of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.50. This value is below the healthy minimum of 4. It has increased from 3.37 (Mar 23) to 3.50, marking an increase of 0.13.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -52.12 (Mar 23) to 0.00, marking an increase of 52.12.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 59.13 (Mar 23) to 0.00, marking a decrease of 59.13.
• For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 152.12 (Mar 23) to 0.00, marking a decrease of 152.12.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 40.87 (Mar 23) to 0.00, marking a decrease of 40.87.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 1.76. This value is below the healthy minimum of 3. It has increased from 1.50 (Mar 23) to 1.76, marking an increase of 0.26.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 0.71. This value is below the healthy minimum of 3. It has increased from 0.31 (Mar 23) to 0.71, marking an increase of 0.40.
• For Enterprise Value (Cr.), as of Mar 24, the value is 679.39. It has increased from 517.00 (Mar 23) to 679.39, marking an increase of 162.39.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.70. This value is below the healthy minimum of 1. It has increased from 0.50 (Mar 23) to 0.70, marking an increase of 0.20.
• For EV / EBITDA (X), as of Mar 24, the value is 11.37. This value is within the healthy range. It has decreased from 14.90 (Mar 23) to 11.37, marking a decrease of 3.53.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.27. This value is below the healthy minimum of 1. It has increased from 0.19 (Mar 23) to 0.27, marking an increase of 0.08.
• For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 152.12 (Mar 23) to 0.00, marking a decrease of 152.12.
• For Price / BV (X), as of Mar 24, the value is 1.98. This value is within the healthy range. It has increased from 1.38 (Mar 23) to 1.98, marking an increase of 0.60.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.27. This value is below the healthy minimum of 1. It has increased from 0.19 (Mar 23) to 0.27, marking an increase of 0.08.
• For EarningsYield, as of Mar 24, the value is -0.03. This value is below the healthy minimum of 5. It has increased from -0.08 (Mar 23) to -0.03, marking an increase of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness